Costeloe, K;
Bowler, U;
Brocklehurst, P;
Hardy, P;
Heal, P;
Juszczak, E;
King, A;
... Millar, MR; + view all
(2016)
A randomised controlled trial of the probiotic Bifidobacterium breve BBG-001 in preterm babies to prevent sepsis, necrotising enterocolitis and death: the Probiotics in Preterm infantS (PiPS) trial.
Health Technology Assessment
, 20
(66)
10.3310/hta20660.
Preview |
Text
Brocklehurst_3003447.pdf - Published Version Download (76MB) | Preview |
Abstract
This is the largest trial to date of a probiotic intervention in preterm infants. This study found that there was no evidence of benefit of this probiotic intervention in reducing late-onset sepsis, necrotising enterocolitis or death. Those findings do not support routine use.
| Type: | Article |
|---|---|
| Title: | A randomised controlled trial of the probiotic Bifidobacterium breve BBG-001 in preterm babies to prevent sepsis, necrotising enterocolitis and death: the Probiotics in Preterm infantS (PiPS) trial |
| Open access status: | An open access version is available from UCL Discovery |
| DOI: | 10.3310/hta20660 |
| Publisher version: | http://doi.org/10.3310/hta20660 |
| Language: | English |
| Additional information: | This version is the version of record. For information on re-use, please refer to the publisher’s terms and conditions. |
| UCL classification: | UCL UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Population Health Sciences > UCL EGA Institute for Womens Health |
| URI: | https://discovery.ucl.ac.uk/id/eprint/1516626 |
Archive Staff Only
 |
View Item |
